PURPOSE: To determine the relationship of increasing body mass index (BMI) and abdominal fat on the effective dose acquired from computed tomography (CT) abdomen and pelvis scans. METHODS: Over 6 months, dose-length product and total milliamp-seconds (mAs) from routine CT abdomen and pelvis scans of 100 patients were recorded. The scans were performed on a 64-slice CT scanner by using an automatic exposure control system. Effective dose (mSv) based on dose-length product, BMI, periumbilical fat thickness, and intra-abdominal fat were documented for each patient. BMI, periumbilical fat thickness, and intra-abdominal fat were compared with effective dose. RESULTS: Thirty-nine men and 61 women were included in the study (mean age, 56.3 years). The mean BMI was 26.2 kg/m(2). The mean effective dose was 10.3 mSv. The mean periumbilical fat thickness was 2.4 cm. Sixty-five patients had a small amount of intra-abdominal fat, and 35 had a large amount of intra-abdominal fat. The effective dose increased with increasing BMI (P < .001) and increasing amounts of intra-abdominal fat (P < .001). For every kilogram of weight, there is a 0.13 mSv increase in effective dose, which is equal to 6.5 chest radiographs per CT examination. For an increase in BMI by 5 kg/m(2), there is a 1.95 mSv increase in effective dose, which is equal to 97.5 chest radiographs per CT examination. CONCLUSION: Increasing BMI and abdominal fat significantly increases the effective dose received from CT abdomen and pelvis scans.
PURPOSE: To determine the relationship of increasing body mass index (BMI) and abdominal fat on the effective dose acquired from computed tomography (CT) abdomen and pelvis scans. METHODS: Over 6 months, dose-length product and total milliamp-seconds (mAs) from routine CT abdomen and pelvis scans of 100 patients were recorded. The scans were performed on a 64-slice CT scanner by using an automatic exposure control system. Effective dose (mSv) based on dose-length product, BMI, periumbilical fat thickness, and intra-abdominal fat were documented for each patient. BMI, periumbilical fat thickness, and intra-abdominal fat were compared with effective dose. RESULTS: Thirty-nine men and 61 women were included in the study (mean age, 56.3 years). The mean BMI was 26.2 kg/m(2). The mean effective dose was 10.3 mSv. The mean periumbilical fat thickness was 2.4 cm. Sixty-five patients had a small amount of intra-abdominal fat, and 35 had a large amount of intra-abdominal fat. The effective dose increased with increasing BMI (P < .001) and increasing amounts of intra-abdominal fat (P < .001). For every kilogram of weight, there is a 0.13 mSv increase in effective dose, which is equal to 6.5 chest radiographs per CT examination. For an increase in BMI by 5 kg/m(2), there is a 1.95 mSv increase in effective dose, which is equal to 97.5 chest radiographs per CT examination. CONCLUSION: Increasing BMI and abdominal fat significantly increases the effective dose received from CT abdomen and pelvis scans.
Authors: Yubing Tong; Jayaram K Udupa; Drew A Torigian; Dewey Odhner; Caiyun Wu; Gargi Pednekar; Scott Palmer; Anna Rozenshtein; Melissa A Shirk; John D Newell; Mary Porteous; Joshua M Diamond; Jason D Christie; David J Lederer Journal: PLoS One Date: 2017-01-03 Impact factor: 3.240
Authors: Konstantinas Povilas Valuckas; Vydmantas Atkocius; Irena Kuzmickiene; Eduardas Aleknavicius; Sarune Liukpetryte; Valerijus Ostapenko Journal: J Radiat Res Date: 2013-02-07 Impact factor: 2.724
Authors: Patrick D McLaughlin; Liam Chawke; Maria Twomey; Kevin P Murphy; Siobhán B O'Neill; Sebastian R McWilliams; Karl James; Richard G Kavanagh; Charles Sullivan; Faimee E Chan; Niamh Moore; Owen J O'Connor; Joseph A Eustace; Michael M Maher Journal: Insights Imaging Date: 2017-10-23